← Back to the feed

arcoris bio AG

History from 14 Feb 2022

UID

CHE-192.823.524

Legal form

AG

Canton

ZH

Founded

14 Feb 2022

Amount raised

not in the SHAB

Lead investor

not in the SHAB

Record

1. SHAB published 17 Feb 2022 · legal date 14 Feb 2022

   Company formed

   Founded 14 Feb 2022

   SHAB HR01-1005407967 ↗

2. SHAB published 14 Feb 2023 · legal date 2 Feb 2023

   Capital band adopted

   SHAB HR02-1005677740 ↗

3. SHAB published 17 Jul 2023 · legal date 5 Jul 2023

   Capital increase

   Not assessed

   Paid in cash

   Nominal capital

   100’000 → 117’389

   Shares

   100’000 → 117’389

   New shares, % of post-step shares

   14.8% (17’389 new)

   SHAB HR02-1005796788 ↗

4. SHAB published 23 Apr 2024 · legal date 11 Apr 2024

   Capital increase

   Not assessed

   Paid in cash

   Nominal capital

   117’389 → 129’152

   Shares

   117’389 → 129’152

   New shares, % of post-step shares

   9.1% (11’763 new)

   SHAB HR02-1006015443 ↗

5. SHAB published 10 Sep 2025 · legal date 3 Sep 2025

   Capital increase

   ●●○Likely financing

   Paid in cash

   Nominal capital

   129’152 → 176’225

   Shares

   129’152 → 176’225

   New shares, % of post-step shares

   26.7% (47’073 new)

   • The increase is an odd amount in small-nominal shares, as priced rounds usually are.+1.0
   • The company was founded less than six years before this capital increase.+0.5
   • The company's purpose describes technology or life-sciences development.+0.5

   Classifier score 0.85 · likely-financing threshold 0.60 · not a calibrated probability

   SHAB HR02-1006429133 ↗

6. SHAB published 10 Sep 2025 · legal date 3 Sep 2025

   Capital band adopted

   SHAB HR02-1006429133 ↗

7. SHAB published 3 Oct 2025 · legal date 18 Sep 2025

   Capital increase

   ◐○○Capital increased · undecided

   Paid in cash

   Nominal capital

   176’225 → 184’051

   Shares

   176’225 → 184’051

   New shares, % of post-step shares

   4.3% (7’826 new)

   • The increase is an odd amount in small-nominal shares, as priced rounds usually are.+1.0
   • The company was founded less than six years before this capital increase.+0.5
   • The company's purpose describes technology or life-sciences development.+0.5

   Classifier score 0.55 · likely-financing threshold 0.60 · not a calibrated probability

   SHAB HR02-1006448330 ↗

8. SHAB published 15 Sep 2026 · legal date 2 Sep 2026

   Capital increase

   ●●○Likely financing

   Paid in cash

   Nominal capital

   184’051 → 220’671

   Shares

   184’051 → 220’671

   New shares, % of post-step shares

   16.6% (36’620 new)

   • The increase is an odd amount in small-nominal shares, as priced rounds usually are.+1.0
   • The company was founded less than six years before this capital increase.+0.5
   • The company's purpose describes technology or life-sciences development.+0.5

   Classifier score 0.78 · likely-financing threshold 0.60 · not a calibrated probability

   SHAB HR02-1006756239 ↗

Published by 20 Sep 2026

Latest available record · 8 Oct 2026